Home Cart Sign in  
Chemical Structure| 1012054-59-9 Chemical Structure| 1012054-59-9

Structure of CUDC-101
CAS No.: 1012054-59-9

Chemical Structure| 1012054-59-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CUDC-101 is a potent HDAC, EGFR, and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively. It is a click chemical probe containing an alkyne group for copper-catalyzed azide-alkyne cycloaddition (CuAAc).

Synonyms: CUDC-101

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CUDC-101

CAS No. :1012054-59-9
Formula : C24H26N4O4
M.W : 434.49
SMILES Code : O=C(NO)CCCCCCOC1=CC2=C(NC3=CC=CC(C#C)=C3)N=CN=C2C=C1OC
Synonyms :
CUDC-101
MDL No. :MFCD15528940
InChI Key :PLIVFNIUGLLCEK-UHFFFAOYSA-N
Pubchem ID :24756910

Safety of CUDC-101

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CUDC-101

epigenetics
RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • HDAC8

    HDAC8, IC50:79.8 nM

  • HDAC10

    HDAC10, IC50:26.1 nM

  • HDAC3

    HDAC3, IC50:9.1 nM

  • HDAC4

    HDAC4, IC50:13.2 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00728793 Tumors PHASE1 COMPLETED 2025-04-10 Karmanos Cancer Institute, Det... More >>roit, Michigan, 48201, United States|START (South Texas Accelerated Research Therapeutics), San Antonio, Texas, 78229, United States Less <<
NCT01702285 Cancer PHASE1 TERMINATED 2025-12-12 Karmanos Cancer Institute, Det... More >>roit, Michigan, 48201, United States|Southern Texas Accelerated Research Therapeutics, San Antonio, Texas, 78229, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.30mL

0.46mL

0.23mL

11.51mL

2.30mL

1.15mL

23.02mL

4.60mL

2.30mL

References

 

Historical Records

Categories